SGLT2i and Primary Prevention of Cancer Therapy-Related Cardiac Dysfunction in Patients With Diabetes

By sjmartinez • January 13, 2025

Bhatti AW, Patel R, Dani SS, Khadke S, Makwana B, Lessey C, Shah J, Al-Husami Z, Yang EH, Thavendiranathan P, Neilan TG, Sadler D, Cheng RK, Dent SF, Liu J, Lopez-Fernandez T, Herrmann J, Scherrer-Crosbie M, Lenihan DJ, Hayek SS, Ky B, Deswal A, Barac A, Nohria A, Ganatra S. SGLT2i and Primary Prevention of Cancer Therapy-Related Cardiac Dysfunction in Patients With Diabetes. JACC CardioOncol. 2024 Sep 22;6(6):863-875. doi: 10.1016/j.jaccao.2024.08.001. PMID: 39801650; PMCID: PMC11711834.

Tags: antineoplastic therapy, Cardiology/Epi, cardiomyopathy, CTRCD, primary prevention, Publications, sodium glucose co-transporter 2 inhibitors

Differences in Ambulatory Care Outcomes Between Trainees and Faculty: A Multi-center Study

Graham KL, Amat M, Norian E, Li J, Weintraub J, Shaik A, Boggan JC, Davy J, Lyons A, Semour L, Rogers R, Davis RB. Differences[...]

Comparative assessment of CAC and SIS plaque burden categories via AI-guided quantitative CT analysis

Iskander B, Ichikawa K, Punnanithinont N, Kambalapalli S, Kinninger A, Krishnan S, Lakshmanan S, Roy S, Budoff MJ. Comparative assessment of CAC and SIS plaque[...]

Association of Mechanical Circulatory Support and Cardiac Catheterization Laboratory Procedural Volumes with Outcomes of Cardiogenic Shock

Tabibian K, Vadlakonda A, Coaston T, Sakowitz S, Ebrahimian S, Srivastava PK, Benharash P. Association of Mechanical Circulatory Support and Cardiac Catheterization Laboratory Procedural Volumes[...]